-
1
-
-
0037370476
-
The genetics and genomics of cancer
-
Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003; 33: 238-244.
-
(2003)
Nat Genet
, vol.33
, pp. 238-244
-
-
Balmain, A.1
Gray, J.2
Ponder, B.3
-
2
-
-
0028856381
-
Proportion of breast cancer cases in the United States explained by well-established risk factors
-
Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995; 87: 1681-1685.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1681-1685
-
-
Madigan, M.P.1
Ziegler, R.G.2
Benichou, J.3
Byrne, C.4
Hoover, R.N.5
-
3
-
-
0034855105
-
Hypoxia and oxidative stress in breast cancer. Oxidative stress: Its effects on the growth, metastatic potential and response to therapy of breast cancer
-
Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 2001; 3: 323-327.
-
(2001)
Breast Cancer Res
, vol.3
, pp. 323-327
-
-
Brown, N.S.1
Bicknell, R.2
-
4
-
-
0001047585
-
Reactive oxygen species: Oxidative damage and pathogenesis
-
Bandyopadyay U, Das D, Banerjee RK. Reactive oxygen species: oxidative damage and pathogenesis. Curr Sci 1999; 77: 658-666.
-
(1999)
Curr Sci
, vol.77
, pp. 658-666
-
-
Bandyopadyay, U.1
Das, D.2
Banerjee, R.K.3
-
5
-
-
0031956813
-
The role of oxidative stress in chemical carcinogenesis
-
Klaunig JE, Xu Y, Isenberg JS, Bachowski Kolaja KL, Jiang J, Stevenson DE, Walborg EF. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 1998; 106: 289-295.
-
(1998)
Environ Health Perspect
, vol.106
, pp. 289-295
-
-
Klaunig, J.E.1
Xu, Y.2
Isenberg, J.S.3
Bachowski Kolaja, K.L.4
Jiang, J.5
Stevenson, D.E.6
Walborg, E.F.7
-
6
-
-
33748977254
-
Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis
-
Karihtala P, Winquist R, Syvaoja JE, Kinnula VL, Soini Y. Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur J Cancer 2006; 42: 2653-2659.
-
(2006)
Eur J Cancer
, vol.42
, pp. 2653-2659
-
-
Karihtala, P.1
Winquist, R.2
Syvaoja, J.E.3
Kinnula, V.L.4
Soini, Y.5
-
7
-
-
0348049803
-
Reactive oxygen species in oncogenic transformation
-
Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003; 31: 1441-1444.
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 1441-1444
-
-
Behrend, L.1
Henderson, G.2
Zwacka, R.M.3
-
8
-
-
0036845966
-
Oxidants, antioxidants and carcinogenesis
-
Ray G, Husain SA. Oxidants, antioxidants and carcinogenesis. Indian J Exp Biol 2002; 40: 1213-1232.
-
(2002)
Indian J Exp Biol
, vol.40
, pp. 1213-1232
-
-
Ray, G.1
Husain, S.A.2
-
9
-
-
0035078318
-
Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins
-
Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001; 306: 1-17.
-
(2001)
Clin Chim Acta
, vol.306
, pp. 1-17
-
-
Abuja, P.M.1
Albertini, R.2
-
10
-
-
0033951258
-
What is oxidative stress?
-
Betteridge DJ. What is oxidative stress? Metabolism 2000; 49: 3-8.
-
(2000)
Metabolism
, vol.49
, pp. 3-8
-
-
Betteridge, D.J.1
-
11
-
-
0034058343
-
Lipid peroxidation, free radical production and antioxidant status in breast cancer
-
Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SA. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 2000; 59: 163-170.
-
(2000)
Breast Cancer Res Treat
, vol.59
, pp. 163-170
-
-
Ray, G.1
Batra, S.2
Shukla, N.K.3
Deo, S.4
Raina, V.5
Ashok, S.6
Husain, S.A.7
-
12
-
-
0036843062
-
Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast
-
Kumaraguruparan R, Subapriya R, Viswanathan P, Nagini S. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta 2002; 325: 165-170.
-
(2002)
Clin Chim Acta
, vol.325
, pp. 165-170
-
-
Kumaraguruparan, R.1
Subapriya, R.2
Viswanathan, P.3
Nagini, S.4
-
13
-
-
0035992583
-
Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast
-
Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002; 35: 275-279.
-
(2002)
Clin Biochem
, vol.35
, pp. 275-279
-
-
Kumaraguruparan, R.1
Subapriya, R.2
Kabalimoorthy, J.3
Nagini, S.4
-
15
-
-
0032738333
-
-
Murr C, Bergant A., Widschwendter, Heim K, Schröcksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin Chem 1999; 45: 1998-2004.
-
Murr C, Bergant A., Widschwendter, Heim K, Schröcksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin Chem 1999; 45: 1998-2004.
-
-
-
-
17
-
-
0026303758
-
Neopterin as a marker for activated cell-mediated immunity: Application in malignant disease
-
Reibnegger G, Fuchs D, Fuith LC, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect Prev 1991; 15: 483-490.
-
(1991)
Cancer Detect Prev
, vol.15
, pp. 483-490
-
-
Reibnegger, G.1
Fuchs, D.2
Fuith, L.C.3
Hausen, A.4
Werner, E.R.5
Werner-Felmayer, G.6
Wachter, H.7
-
18
-
-
0024308582
-
Neopterin as marker for activation of cellular immunity: Immunologic basis and clinical application
-
Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81-141.
-
(1989)
Adv Clin Chem
, vol.27
, pp. 81-141
-
-
Wachter, H.1
Fuchs, D.2
Hausen, A.3
Reibnegger, G.4
Werner, E.R.5
-
20
-
-
0021318441
-
-
Aebi H. Catalase in vitro. Meth Enzymol 1984; 105: 121-126.
-
Aebi H. Catalase in vitro. Meth Enzymol 1984; 105: 121-126.
-
-
-
-
21
-
-
0016272750
-
Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase
-
Marklund S, Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
-
(1974)
Eur J Biochem
, vol.47
, pp. 469-474
-
-
Marklund, S.1
Marklund, G.2
-
22
-
-
9844256470
-
Protein determination for large numbers of samples
-
Miller GL. Protein determination for large numbers of samples. Anal Chem 1959; 31: 964.
-
(1959)
Anal Chem
, vol.31
, pp. 964
-
-
Miller, G.L.1
-
23
-
-
38549159170
-
Breast cancer prognostication and prediction are we making progress?
-
Lonning PE. Breast cancer prognostication and prediction are we making progress? Ann Oncol 2007; 18: 3-7.
-
(2007)
Ann Oncol
, vol.18
, pp. 3-7
-
-
Lonning, P.E.1
-
24
-
-
33645337897
-
Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies
-
Melichar B, Solichova D, Freedman RS. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int Gynecol Cancer 2006; 16: 240-252.
-
(2006)
Int Gynecol Cancer
, vol.16
, pp. 240-252
-
-
Melichar, B.1
Solichova, D.2
Freedman, R.S.3
-
25
-
-
33947405728
-
Systemic immune activation, anemia and thrombocytosis in breast cancer patients treated by doxorubicin and paclitaxel
-
Melichar B, Solichova D, Melicharova K, Cermanova M, Urminska H, Ryska A. Systemic immune activation, anemia and thrombocytosis in breast cancer patients treated by doxorubicin and paclitaxel. Pteridines 2006; 17: 107-114.
-
(2006)
Pteridines
, vol.17
, pp. 107-114
-
-
Melichar, B.1
Solichova, D.2
Melicharova, K.3
Cermanova, M.4
Urminska, H.5
Ryska, A.6
-
27
-
-
0021264311
-
Immune response-associated production of neopterin - Release from macrophages primarily under control of interferongamma
-
Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. Immune response-associated production of neopterin - Release from macrophages primarily under control of interferongamma. J Exp Med 1984; 160: 310-316.
-
(1984)
J Exp Med
, vol.160
, pp. 310-316
-
-
Huber, C.1
Batchelor, J.R.2
Fuchs, D.3
Hausen, A.4
Lang, A.5
Niederwieser, D.6
Reibnegger, G.7
Swetly, P.8
Troppmair, J.9
Wachter, H.10
-
29
-
-
0027066967
-
The role of neopterin as a monitor of cellular activation in transplantation, inflammatory, infectious and malignant disease
-
Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular activation in transplantation, inflammatory, infectious and malignant disease. Crit Rev Clin Chem 1992; 29: 307-341.
-
(1992)
Crit Rev Clin Chem
, vol.29
, pp. 307-341
-
-
Fuchs, D.1
Weiss, G.2
Reibnegger, G.3
Wachter, H.4
-
30
-
-
0023736398
-
Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma
-
Kawasaki H, Watanabe H, Yamada S, Watanabe K, Suyama A. Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma. Tohoku J Exp Med 1988; 155: 311-318.
-
(1988)
Tohoku J Exp Med
, vol.155
, pp. 311-318
-
-
Kawasaki, H.1
Watanabe, H.2
Yamada, S.3
Watanabe, K.4
Suyama, A.5
-
31
-
-
28644431685
-
Blood superoxide dismutase and catalase activities in women affected with breast cancer
-
Negahdar M, Djalali M, Abtahi H, Sadeghi MR, Aghvami T, Javadi E, Layegh H. Blood superoxide dismutase and catalase activities in women affected with breast cancer. Iranian J Publ Health 2005; 34: 39-43.
-
(2005)
Iranian J Publ Health
, vol.34
, pp. 39-43
-
-
Negahdar, M.1
Djalali, M.2
Abtahi, H.3
Sadeghi, M.R.4
Aghvami, T.5
Javadi, E.6
Layegh, H.7
-
32
-
-
39049162119
-
-
Wachter H, Fuchs D, Hausen G, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G. Neopterin: Biochemistry, Methods, Clinical Application. Berlin- New York: Walter de Gruyter 1992.
-
Wachter H, Fuchs D, Hausen G, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G. Neopterin: Biochemistry, Methods, Clinical Application. Berlin- New York: Walter de Gruyter 1992.
-
-
-
-
33
-
-
34547728233
-
Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma
-
Melichar B, Touskova M, Hornychova H, Vokurkova D, Solichova, Vesely P, Mergancova, Urminska H, Ryska A. Systemic immune activation and peripheral blood lymphocytes during primary chemotherapy with the combination of doxorubicin and paclitaxel in patients with breast carcinoma. Pteridines 2007; 18: 25-34.
-
(2007)
Pteridines
, vol.18
, pp. 25-34
-
-
Melichar, B.1
Touskova, M.2
Hornychova, H.3
Vokurkova, D.4
Solichova5
Vesely, P.6
Mergancova7
Urminska, H.8
Ryska, A.9
|